Novanta is trading 4.16% up at $147.10 in pre-market on September 30, 2026; the catalyst remains unclear.

  • The company’s investor-news page lists its latest 2026 release on August 28, not September 29 or 30.
  • Provided major-index moves are modestly negative and do not clearly explain Novanta’s gain.